Oakwell Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Buy
727
+86
+13% +$87.9K 0.14% 48
2026
Q1
$590K Sell
641
-3
-0.5% -$3.04K 0.11% 51
2025
Q4
$692K Buy
644
+56
+10% +$53.5K 0.13% 53
2025
Q3
$449K Sell
588
-28
-5% -$20.8K 0.09% 59
2025
Q2
$480K Sell
616
-9
-1% -$6.99K 0.11% 52
2025
Q1
$516K Buy
625
+158
+34% +$131K 0.14% 46
2024
Q4
$361K Hold
467
0.1% 51
2024
Q3
$414K Hold
467
0.12% 48
2024
Q2
$423K Buy
467
+26
+6% +$20.8K 0.12% 49
2024
Q1
$343K Buy
441
+10
+2% +$7.12K 0.1% 49
2023
Q4
$251K Buy
+431
New +$252K 0.09% 54

Other funds holding LLY

Oakwell Private Wealth Management's LLY Position: Q2 2026 in Review

Oakwell Private Wealth Management increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $87.9K and bringing the position to 727 shares worth $872K. The position accounts for 0.14% of the portfolio, ranked #48.

Oakwell Private Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oakwell Private Wealth Management held 727 shares of Eli Lilly worth $872K as of Q2 2026.
  • Oakwell Private Wealth Management bought 86 Eli Lilly shares in Q2 2026, an estimated $87.9K.
  • Eli Lilly made up 0.14% of Oakwell Private Wealth Management's portfolio in Q2 2026, its #48 holding.
  • Oakwell Private Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oakwell Private Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.